Clinical Trials for Oncotherapeutics

Explore 5 clinical trials worldwide

Showing 1-5 of 5 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Oncotherapeutics

Clinical Trials (5)

NCT06225310
A Trial of Selinexor, Ruxolitinib and Methylprednisolone
PHASE1Recruiting
30 participants
Started: Aug 6, 2024 · Completed: May 1, 2027
2 conditions1 sponsor1 location
NCT06115135
A Study of Venetoclax in Combination With Isatuximab and Dexamethasone for Relapsed/Refractory Multiple Myeloma
PHASE2Recruiting
39 participants
Started: Jun 20, 2024 · Completed: Dec 31, 2027
2 conditions1 sponsor2 locations
NCT06209606
Pilot Study Using Changes in Serum BCMA to Determine Disease Progression in Multiple Myeloma
EARLY_PHASE1Recruiting
30 participants
Started: Dec 8, 2022 · Completed: Feb 28, 2029
1 condition2 sponsors1 location
NCT04519476
Selinexor Treatment for Multiple Myeloma Patients Who Are Refractory to Lenalidomide-containing Therapy.
PHASE1Recruiting
22 participants
Started: Nov 1, 2020 · Completed: Dec 29, 2023
1 condition2 sponsors1 location
NCT03110822
A Phase 1 Study of Ruxolitinib, Steroids and Lenalidomide for Relapsed/Refractory Multiple Myeloma (RRMM) Patients
PHASE1Recruiting
134 participants
Started: Feb 1, 2017 · Completed: Feb 28, 2027
1 condition2 sponsors13 locations